| 引用本文:李晓玲1,2，梁宁2，杨涛杏1,2，杨一玖2，陈雅馨2，胡紫藤2，王晶亚2，张海力2，李慧珍2，焦丽雯2，李安2，宗星煜2，王巍力2，王丁熠2，王尊帅1，赵晨2，王燕平2，史楠楠2，樊新荣3.妇产科中医/中西医指南内容分析与质量评价[J].世界中医药,2022,(08):. |
|
| 妇产科中医/中西医指南内容分析与质量评价 |
| Content Analysis and Quality Evaluation of Traditional Chinese Medicine/Integrated Traditional Chinese and Western Medicine Guidelines for Obstetrics and Gynecology |
| 投稿时间：2021-12-20 |
| DOI：10.3969/j.issn.1673-7202.2022.08.018 |
| 中文关键词: 妇产科 指南 中医 指南研究与评价工具Ⅱ 卫生保健实践指南报告清单 异病同治 指南方法学 指南报告质量 |
| English Keywords:Obstetrics and gynecology Guidelines Traditional Chinese medicine AGREE Ⅱ RIGHT checklist Treat different diseases with the same treatment Guideline methodology Reporting quality of guidelines |
| 基金项目:中国中医科学院科技创新工程资助项目（CI2021A00701，CI2021A00701-4）；国家重点研发计划中医药现代化研究专项（2019YFC1712000）；中央级公益性科研院所基本科研业务费专项资金资助项目（zz14-YQ-039，2020YJSZX-1） |
|
| 摘要点击次数: 525 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的：系统梳理近5年发布的妇产科中医/中西医临床实践指南并进行方法学质量评价和报告质量评价，以期为妇产科中医临床实践提供参考。方法：计算机检索国家知识基础设施数据库（CNKI）、中国学术期刊数据库（CSPD）、中文科技期刊数据库（CCD）、中国生物医学文献服务系统（SinoMed）和PubMed中英文电子数据库，检索时限为2017年1月1日至2021年8月31日。筛选标准为包含中医内容推荐的妇产科相关指南。采取双人交叉录入的方式提取指南基本信息，并采用指南研究与评价工具Ⅱ和卫生保健实践指南报告清单对纳入的指南进行质量评价。结果：共纳入25篇指南，涵盖20种妇产科疾病，涉及中医预防、诊断、治疗3个方面。中医内治法中共有7个中药方剂和12个中成药被指南推荐应用于治疗3种及以上妇产科疾病。指南研究与评价工具Ⅱ评分结果显示纳入指南的清晰性得分最高（65%），应用性最低（14%）；卫生保健实践指南报告清单评价结果显示各条目的平均完全报告率为38%，7个领域中基本信息的完全报告率最高（55%），评审和质量保证的未报告率最高（92%）。结论：纳入的指南质量总体偏低，指南在卫生保健实践指南报告清单的报告率也较低；指南的推荐意见多从“同病异治”入手，可进一步探索指南的“异病同治”规律以促进各指南的应用与临床实践。 |
| English Summary: |
| To systematically summarize the clinical practice guidelines of traditional Chinese medicine(TCM) and integrated traditional Chinese and western medicine in obstetrics and gynecology issued in the last five years, and evaluate the methodological and reporting qualities, to provide reference for the clinical practice of TCM in obstetrics and gynecology. Methods:CNKI, CSPD, CCD, SinoMed and PubMed were searched for guidelines for obstetrics and gynecology that included TCM recommendations from January 1, 2017 to August 31, 2021. Two researcher fellows independently extracted the basic information of the guidelines, and AGREE Ⅱ and RIGHT checklist were used to evaluate the quality of the included guidelines. Results:A total of 25 guidelines were selected, covering 20 obstetric and gynecological diseases and involving the TCM prevention, diagnosis, and treatment. Seven TCM prescriptions and 12 Chinese patent medicines were recommended in the guidelines for the treatment of three or more obstetric and gynecological diseases. The AGREE Ⅱ scoring results showed that the clarity of presentation of the included guidelines was the highest(65%) while the applicability was the lowest(14%). The evaluation results of the RIGHT checklist revealed that the average complete reporting rate of each item was 38%; the complete reporting rate of basic information in seven areas was the highest(55%); the non-reporting rate of review and quality assurance was the highest(92%). Conclusion:The quality of the included guidelines is generally low, and the reporting rate of the guidelines according to the RIGHT checklist is also low. The recommendations of the guidelines mostly focus on “the same disease with different treatments”. However, the rule of “different diseases with the same treatment” can be further explored to promote the application and clinical practice of the guidelines. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
